Daunorubicin and hypoxia Patient Reports February 11, 2012
Daunorubicin Side Effects Report #4562518-0
Daunorubicin side effect was reported by a Health Professional from on Jan 10, 2005. Male patient, 72 years of age, weighting 210.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: haemorrhage, hypoxia, tumour lysis syndrome. Daunorubicin dosage: 45MG/M2 OTHER. Patient was hospitalized. Patient died on 12/03/2004.
Daunorubicin Side Effects Report #4805956-0
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 19, 2005. Female patient, weighting 202.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: atrial fibrillation
, chest pain
, electrocardiogram t wave abnormal, haemodynamic instability, hypotension, hypoxia, infection
, pericardial effusion, pericarditis. Daunorubicin dosage: unknown. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.Daunorubicin Side Effects Report #4805962-6
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 19, 2005. Female patient, weighting 202.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: atrial fibrillation
, chest pain
, electrocardiogram t wave abnormal, haemodynamic instability, hypotension, hypoxia, infection
, pericardial effusion, pericarditis. Daunorubicin dosage: unknown. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.Daunorubicin Side Effects Report #4797401-9
Daunorubicin side effect was reported by a Health Professional from UNITED STATES on Oct 11, 2005. Female patient, 55 years of age, weighting 169.0 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, atrial fibrillation
, dyspnoea, escherichia bacteraemia, hypoxia, metabolic acidosis, rales, renal failure acute, respiratory failure. Daunorubicin dosage: 108MG IV WEEKLY. During the same period patient was treated with ACYCLOVIR, AMPHOGEL, MEROPENEM. Patient was hospitalized. Patient recovered.Daunorubicin Side Effects Report #4865089-4
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 20, 2005. Male patient, weighting 198.4 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain
, hypotension, hypoxia, liver function test abnormal, mental status changes, pancreatitis. Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.Daunorubicin Side Effects Report #4874734-9
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 01, 2006. Male patient, weighting 198.4 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: blood culture positive, convulsion, depressed level of consciousness, electroencephalogram abnormal, fungal infection
, hypotension, hypoxia, mental status changes, multi-organ failure. Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient died.Daunorubicin Side Effects Report #5272643-7
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2007. Male patient, weighting 147.2 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: aeromona infection, disseminated intravascular coagulation, gastrointestinal haemorrhage, hypotension, hypoxia, left ventricular failure, renal failure, respiratory arrest. Daunorubicin dosage: 90 MG. During the same period patient was treated with PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5280206-2
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 26, 2007. Male patient, weighting 147.2 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: aeromona infection, disseminated intravascular coagulation, gastrointestinal haemorrhage, hypotension, hypoxia, left ventricular failure, renal failure, respiratory arrest. Daunorubicin dosage: unknown. During the same period patient was treated with PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5283551-X
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2007. Male patient, weighting 147.2 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: bacterial infection
, disseminated intravascular coagulation, gastrointestinal haemorrhage, hypotension, hypoxia, left ventricular failure, renal failure, respiratory arrest. Daunorubicin dosage: unknown. During the same period patient was treated with PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.Daunorubicin Side Effects Report #5297834-0
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2007. Male patient, weighting 147.2 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: gastrointestinal candidiasis, gastrointestinal haemorrhage, hypotension, hypoxia, left ventricular failure, oral candidiasis, renal failure, respiratory arrest. Daunorubicin dosage: 90 MG. During the same period patient was treated with PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5315631-4
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 30, 2007. Male patient, weighting 147.2 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: aeromona infection, candidiasis, disseminated intravascular coagulation, gastrointestinal haemorrhage, hypotension, hypoxia, left ventricular failure, renal failure, respiratory arrest. Daunorubicin dosage: 90 MG. During the same period patient was treated with PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5355851-6
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on June 11, 2007. Male patient, weighting 147.2 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: aeromona infection, candidiasis, disseminated intravascular coagulation, gastrointestinal haemorrhage, hypotension, hypoxia, left ventricular failure, renal failure, respiratory arrest. Daunorubicin dosage: 90 MG. During the same period patient was treated with PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5373571-9
Daunorubicin side effect was reported by a Consumer or non-health professional from AUSTRALIA on June 26, 2007. Male patient, weighting 147.2 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: aeromona infection, candidiasis, cardiac arrest
, disseminated intravascular coagulation, gastrointestinal haemorrhage, hypotension, hypoxia, renal failure. Daunorubicin dosage: unknown. During the same period patient was treated with PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.Daunorubicin Side Effects Report #5120906-8
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2006. Female patient, weighting 154.3 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: bacillus infection, disseminated intravascular coagulation, hypotension, hypoxia, pulmonary haemorrhage, pyrexia. Daunorubicin dosage: 88 MG. During the same period patient was treated with DEXAMETHASONE, CYTARABINE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5130438-9
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 17, 2006. Female patient, weighting 154.3 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: bacillus infection, disseminated intravascular coagulation, hypotension, hypoxia, pulmonary haemorrhage, pyrexia. Daunorubicin dosage: 88 MG. During the same period patient was treated with CYTARABINE, DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5146230-5
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 06, 2006. Female patient, weighting 235.2 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: blood pressure decreased, cardiac failure, dyspnoea, hypotension, hypoxia, sepsis
. Daunorubicin dosage: 90 MG. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.
Daunorubicin and hypoxia 